Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 22 | 2024 | 1203 | 2.880 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2023 | 3250 | 2.260 |
Why?
|
Diabetes Mellitus | 27 | 2021 | 5888 | 1.990 |
Why?
|
Hypoglycemic Agents | 15 | 2024 | 3108 | 1.910 |
Why?
|
Medical Records Systems, Computerized | 13 | 2010 | 1196 | 1.730 |
Why?
|
Data Mining | 5 | 2019 | 560 | 1.690 |
Why?
|
Medication Errors | 10 | 2014 | 784 | 1.400 |
Why?
|
Electronic Health Records | 21 | 2021 | 4880 | 1.370 |
Why?
|
Insulin | 11 | 2024 | 6608 | 1.360 |
Why?
|
Hypoglycemia | 5 | 2024 | 896 | 1.340 |
Why?
|
Counseling | 5 | 2019 | 1550 | 1.340 |
Why?
|
Treatment Refusal | 4 | 2020 | 433 | 1.310 |
Why?
|
Antihypertensive Agents | 10 | 2023 | 2030 | 1.200 |
Why?
|
Electronic Prescribing | 4 | 2014 | 115 | 1.180 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12246 | 1.080 |
Why?
|
Medical Records | 6 | 2012 | 1408 | 1.040 |
Why?
|
Hypertension | 15 | 2023 | 8616 | 0.990 |
Why?
|
Medication Reconciliation | 3 | 2018 | 153 | 0.910 |
Why?
|
Software | 11 | 2018 | 4464 | 0.900 |
Why?
|
Blood Pressure Determination | 3 | 2015 | 646 | 0.890 |
Why?
|
Incretins | 1 | 2024 | 100 | 0.860 |
Why?
|
Documentation | 8 | 2017 | 914 | 0.850 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 157 | 0.820 |
Why?
|
Primary Health Care | 9 | 2019 | 4735 | 0.820 |
Why?
|
Blood Glucose | 9 | 2024 | 6422 | 0.770 |
Why?
|
Hyperkalemia | 1 | 2023 | 233 | 0.700 |
Why?
|
Hypercholesterolemia | 4 | 2013 | 1145 | 0.700 |
Why?
|
Blood Pressure | 9 | 2019 | 8533 | 0.700 |
Why?
|
Life Style | 5 | 2019 | 3926 | 0.700 |
Why?
|
Medication Adherence | 2 | 2024 | 2190 | 0.690 |
Why?
|
Medication Systems, Hospital | 4 | 2008 | 154 | 0.680 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2024 | 317 | 0.680 |
Why?
|
Hyperaldosteronism | 1 | 2023 | 252 | 0.680 |
Why?
|
Coronary Artery Disease | 7 | 2024 | 6575 | 0.660 |
Why?
|
Office Visits | 4 | 2011 | 593 | 0.650 |
Why?
|
Forms and Records Control | 2 | 2011 | 158 | 0.610 |
Why?
|
Retrospective Studies | 41 | 2024 | 81657 | 0.610 |
Why?
|
Metformin | 2 | 2024 | 907 | 0.610 |
Why?
|
Physicians, Primary Care | 5 | 2020 | 622 | 0.580 |
Why?
|
User-Computer Interface | 6 | 2019 | 1409 | 0.570 |
Why?
|
Diabetes Complications | 3 | 2020 | 1319 | 0.560 |
Why?
|
Medical Order Entry Systems | 4 | 2010 | 523 | 0.540 |
Why?
|
Aldosterone | 5 | 2023 | 881 | 0.530 |
Why?
|
Continuity of Patient Care | 5 | 2011 | 1077 | 0.520 |
Why?
|
Cholesterol | 4 | 2018 | 2904 | 0.510 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 975 | 0.490 |
Why?
|
Hyperglycemia | 2 | 2017 | 1389 | 0.470 |
Why?
|
Patient Compliance | 3 | 2010 | 2694 | 0.460 |
Why?
|
Algorithms | 15 | 2021 | 14073 | 0.460 |
Why?
|
Databases, Factual | 5 | 2024 | 8065 | 0.460 |
Why?
|
Decision Support Systems, Clinical | 5 | 2023 | 1178 | 0.450 |
Why?
|
Bariatric Surgery | 2 | 2021 | 996 | 0.440 |
Why?
|
Ambulatory Care Information Systems | 2 | 2011 | 89 | 0.440 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15652 | 0.430 |
Why?
|
Vocabulary, Controlled | 3 | 2014 | 170 | 0.410 |
Why?
|
Narration | 3 | 2012 | 223 | 0.410 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2306 | 0.410 |
Why?
|
Humans | 110 | 2024 | 766812 | 0.410 |
Why?
|
Information Storage and Retrieval | 4 | 2017 | 832 | 0.410 |
Why?
|
Data Collection | 4 | 2010 | 3321 | 0.400 |
Why?
|
Fees and Charges | 1 | 2013 | 189 | 0.400 |
Why?
|
Ambulatory Care | 3 | 2020 | 2779 | 0.390 |
Why?
|
Emergencies | 1 | 2018 | 1223 | 0.380 |
Why?
|
Medication Systems | 1 | 2010 | 31 | 0.350 |
Why?
|
Risk Reduction Behavior | 2 | 2015 | 1120 | 0.350 |
Why?
|
Laboratories, Hospital | 1 | 2012 | 192 | 0.350 |
Why?
|
Aged | 39 | 2024 | 171344 | 0.340 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1292 | 0.340 |
Why?
|
Middle Aged | 46 | 2024 | 223267 | 0.340 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 388 | 0.340 |
Why?
|
Home Nursing | 1 | 2010 | 92 | 0.340 |
Why?
|
Subject Headings | 1 | 2008 | 16 | 0.320 |
Why?
|
Male | 56 | 2024 | 364154 | 0.310 |
Why?
|
Hospital Mortality | 5 | 2021 | 5344 | 0.300 |
Why?
|
Hospitalization | 5 | 2022 | 10816 | 0.300 |
Why?
|
Pattern Recognition, Automated | 3 | 2008 | 980 | 0.300 |
Why?
|
Medical History Taking | 2 | 2008 | 779 | 0.290 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 497 | 0.290 |
Why?
|
ROC Curve | 4 | 2021 | 3621 | 0.290 |
Why?
|
Warfarin | 2 | 2017 | 1493 | 0.290 |
Why?
|
Drug Utilization Review | 1 | 2008 | 248 | 0.280 |
Why?
|
Female | 55 | 2024 | 396532 | 0.280 |
Why?
|
Physicians | 4 | 2010 | 4591 | 0.280 |
Why?
|
Logistic Models | 2 | 2019 | 13276 | 0.280 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 677 | 0.280 |
Why?
|
Drug Prescriptions | 3 | 2017 | 1663 | 0.270 |
Why?
|
Appointments and Schedules | 1 | 2010 | 442 | 0.270 |
Why?
|
Cohort Studies | 12 | 2024 | 41706 | 0.260 |
Why?
|
Diagnostic Tests, Routine | 1 | 2012 | 788 | 0.260 |
Why?
|
Heart Failure | 5 | 2023 | 11879 | 0.260 |
Why?
|
Multivariate Analysis | 7 | 2021 | 12064 | 0.260 |
Why?
|
Lipoprotein-X | 1 | 2005 | 5 | 0.250 |
Why?
|
Internet | 4 | 2002 | 3113 | 0.240 |
Why?
|
Intensive Care Units | 1 | 2018 | 3799 | 0.240 |
Why?
|
Prediabetic State | 2 | 2024 | 547 | 0.240 |
Why?
|
Database Management Systems | 2 | 2006 | 263 | 0.230 |
Why?
|
Certification | 1 | 2008 | 420 | 0.230 |
Why?
|
Adult | 23 | 2024 | 223305 | 0.230 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2024 | 93 | 0.230 |
Why?
|
Renin | 2 | 2023 | 647 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2447 | 0.220 |
Why?
|
Anticoagulants | 3 | 2017 | 4854 | 0.220 |
Why?
|
Databases, Genetic | 2 | 2018 | 1756 | 0.220 |
Why?
|
Biomedical Research | 3 | 2020 | 3459 | 0.220 |
Why?
|
Mineralocorticoids | 1 | 2023 | 37 | 0.220 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2003 | 59 | 0.220 |
Why?
|
Quality of Health Care | 2 | 2018 | 4306 | 0.220 |
Why?
|
Health Personnel | 1 | 2017 | 3384 | 0.210 |
Why?
|
Amiloride | 1 | 2022 | 116 | 0.210 |
Why?
|
Research Personnel | 2 | 2018 | 589 | 0.210 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 806 | 0.200 |
Why?
|
Sequence Homology | 1 | 2002 | 197 | 0.200 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2024 | 1564 | 0.200 |
Why?
|
Lisinopril | 1 | 2022 | 60 | 0.200 |
Why?
|
Inpatients | 3 | 2022 | 2566 | 0.200 |
Why?
|
Registries | 9 | 2023 | 8352 | 0.190 |
Why?
|
Atherosclerosis | 3 | 2023 | 3421 | 0.190 |
Why?
|
Drug Approval | 1 | 2008 | 820 | 0.190 |
Why?
|
Withholding Treatment | 2 | 2017 | 619 | 0.180 |
Why?
|
Hyponatremia | 1 | 2003 | 278 | 0.180 |
Why?
|
Ibuprofen | 1 | 2022 | 228 | 0.180 |
Why?
|
Time Factors | 8 | 2024 | 40149 | 0.180 |
Why?
|
Hemorrhage | 2 | 2017 | 3464 | 0.180 |
Why?
|
Thromboembolism | 2 | 2017 | 1003 | 0.180 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2023 | 0.180 |
Why?
|
Body Mass Index | 3 | 2015 | 13050 | 0.170 |
Why?
|
Medical Errors | 1 | 2008 | 1260 | 0.170 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2022 | 164 | 0.170 |
Why?
|
Endocardial Cushion Defects | 1 | 2000 | 43 | 0.170 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2021 | 91 | 0.170 |
Why?
|
Risk Factors | 17 | 2024 | 74889 | 0.170 |
Why?
|
Clinical Pharmacy Information Systems | 3 | 2009 | 102 | 0.170 |
Why?
|
Administration, Oral | 3 | 2024 | 4019 | 0.170 |
Why?
|
Situs Inversus | 1 | 2000 | 63 | 0.170 |
Why?
|
Artificial Intelligence | 3 | 2008 | 2662 | 0.170 |
Why?
|
Proteinuria | 1 | 2023 | 613 | 0.170 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 1086 | 0.160 |
Why?
|
Thiazolidinediones | 1 | 2022 | 460 | 0.160 |
Why?
|
United States | 17 | 2024 | 72945 | 0.160 |
Why?
|
Computer-Assisted Instruction | 2 | 2000 | 368 | 0.160 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59548 | 0.160 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2694 | 0.160 |
Why?
|
Massachusetts | 7 | 2020 | 8890 | 0.150 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1514 | 0.150 |
Why?
|
Potassium | 1 | 2023 | 1314 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2022 | 2232 | 0.150 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 736 | 0.150 |
Why?
|
Directive Counseling | 1 | 2019 | 171 | 0.150 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 856 | 0.150 |
Why?
|
Pneumococcal Vaccines | 2 | 2013 | 414 | 0.150 |
Why?
|
Gout | 1 | 2024 | 622 | 0.140 |
Why?
|
Fee-for-Service Plans | 2 | 2020 | 713 | 0.140 |
Why?
|
Length of Stay | 2 | 2018 | 6491 | 0.140 |
Why?
|
Pneumococcal Infections | 2 | 2013 | 529 | 0.140 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2730 | 0.140 |
Why?
|
Problem-Based Learning | 1 | 2000 | 360 | 0.130 |
Why?
|
Education, Distance | 1 | 2000 | 260 | 0.130 |
Why?
|
Antibody Diversity | 1 | 1996 | 72 | 0.130 |
Why?
|
Hospitals, General | 2 | 2011 | 804 | 0.130 |
Why?
|
Immunocompromised Host | 2 | 2013 | 865 | 0.130 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2392 | 0.130 |
Why?
|
Incidence | 6 | 2024 | 21527 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2019 | 1241 | 0.130 |
Why?
|
Liver Diseases | 1 | 2005 | 1303 | 0.130 |
Why?
|
Hypolipidemic Agents | 1 | 2020 | 609 | 0.130 |
Why?
|
Splenectomy | 1 | 2017 | 390 | 0.130 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1804 | 0.130 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1677 | 0.130 |
Why?
|
Quality Improvement | 4 | 2017 | 3850 | 0.130 |
Why?
|
Patient Readmission | 2 | 2021 | 3283 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 489 | 0.130 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12536 | 0.120 |
Why?
|
Sex Factors | 3 | 2020 | 10619 | 0.120 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 1478 | 0.120 |
Why?
|
Genes, Immunoglobulin | 1 | 1996 | 283 | 0.120 |
Why?
|
Advance Care Planning | 1 | 2023 | 698 | 0.120 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 101 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3230 | 0.120 |
Why?
|
Immunoglobulin Variable Region | 1 | 1996 | 419 | 0.120 |
Why?
|
Hospitals, Teaching | 2 | 2011 | 1156 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2000 | 830 | 0.120 |
Why?
|
Quality Assurance, Health Care | 4 | 2011 | 2171 | 0.120 |
Why?
|
DNA Primers | 1 | 1999 | 2826 | 0.120 |
Why?
|
Age Factors | 4 | 2020 | 18397 | 0.120 |
Why?
|
Myocardium | 2 | 2011 | 4765 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1337 | 0.110 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5182 | 0.110 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3927 | 0.110 |
Why?
|
Medicare Part C | 1 | 2019 | 333 | 0.110 |
Why?
|
Online Systems | 1 | 2014 | 181 | 0.110 |
Why?
|
Patient Admission | 4 | 2008 | 1364 | 0.110 |
Why?
|
Lung Diseases | 1 | 2003 | 1940 | 0.110 |
Why?
|
Heart | 1 | 2006 | 4425 | 0.100 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 41 | 0.100 |
Why?
|
Systole | 1 | 2015 | 935 | 0.100 |
Why?
|
Calciphylaxis | 1 | 2014 | 129 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2189 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7870 | 0.100 |
Why?
|
Coronary Angiography | 1 | 2024 | 4525 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2005 | 3079 | 0.100 |
Why?
|
Uremia | 1 | 2013 | 202 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39312 | 0.100 |
Why?
|
Disease Progression | 3 | 2022 | 13642 | 0.100 |
Why?
|
Prognosis | 3 | 2019 | 29959 | 0.100 |
Why?
|
Video Games | 1 | 2014 | 202 | 0.090 |
Why?
|
Medicare | 2 | 2020 | 6813 | 0.090 |
Why?
|
Outpatients | 2 | 2017 | 1596 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2659 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3618 | 0.090 |
Why?
|
Social Class | 1 | 2020 | 2007 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2016 | 732 | 0.090 |
Why?
|
Stroke | 3 | 2017 | 9744 | 0.090 |
Why?
|
Aspirin | 1 | 2022 | 3134 | 0.090 |
Why?
|
Terminal Care | 1 | 2023 | 1769 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15425 | 0.090 |
Why?
|
Hospital Departments | 1 | 2011 | 134 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2011 | 167 | 0.090 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 238 | 0.090 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9528 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6306 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3934 | 0.080 |
Why?
|
Systems Integration | 1 | 2011 | 425 | 0.080 |
Why?
|
Treatment Outcome | 6 | 2024 | 65286 | 0.080 |
Why?
|
Patients' Rooms | 1 | 2009 | 63 | 0.080 |
Why?
|
Medical Record Linkage | 1 | 2010 | 286 | 0.080 |
Why?
|
Prevalence | 3 | 2017 | 15835 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2011 | 2783 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2253 | 0.080 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2010 | 198 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.080 |
Why?
|
Observation | 1 | 2010 | 310 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 253 | 0.080 |
Why?
|
Stroke Volume | 2 | 2022 | 5618 | 0.080 |
Why?
|
Dictionaries as Topic | 1 | 2007 | 11 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 11924 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14653 | 0.070 |
Why?
|
Odds Ratio | 2 | 2017 | 9661 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2667 | 0.070 |
Why?
|
Quality Control | 1 | 2010 | 834 | 0.070 |
Why?
|
Research Report | 1 | 2010 | 367 | 0.070 |
Why?
|
Heart Rate | 1 | 2019 | 4207 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 348 | 0.070 |
Why?
|
Education, Medical | 1 | 1999 | 1744 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 454 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2233 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1936 | 0.070 |
Why?
|
Critical Pathways | 1 | 2009 | 475 | 0.060 |
Why?
|
Mortality | 1 | 2017 | 2908 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3411 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2334 | 0.060 |
Why?
|
Efficiency | 1 | 2008 | 479 | 0.060 |
Why?
|
Self Care | 1 | 2010 | 800 | 0.060 |
Why?
|
Risk Assessment | 4 | 2020 | 24299 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.060 |
Why?
|
Drug Utilization | 1 | 2010 | 1188 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2010 | 962 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.060 |
Why?
|
Hospital Information Systems | 1 | 2007 | 395 | 0.060 |
Why?
|
Radiation Oncology | 1 | 2010 | 572 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1217 | 0.060 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 602 | 0.060 |
Why?
|
Diagnosis | 1 | 2005 | 157 | 0.060 |
Why?
|
Software Design | 2 | 2006 | 173 | 0.060 |
Why?
|
Electronics | 1 | 2005 | 315 | 0.060 |
Why?
|
Rheumatic Diseases | 1 | 2010 | 657 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.050 |
Why?
|
Aortic Valve | 2 | 2024 | 1966 | 0.050 |
Why?
|
Patient Discharge | 3 | 2011 | 3466 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2003 | 655 | 0.050 |
Why?
|
Liver Function Tests | 1 | 2003 | 527 | 0.050 |
Why?
|
Databases, Nucleic Acid | 1 | 2002 | 203 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2003 | 434 | 0.050 |
Why?
|
Bilirubin | 1 | 2003 | 440 | 0.050 |
Why?
|
Cholestasis | 1 | 2005 | 385 | 0.050 |
Why?
|
Income | 1 | 2010 | 1876 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9346 | 0.050 |
Why?
|
Echocardiography | 2 | 2024 | 5038 | 0.050 |
Why?
|
Pituitary Apoplexy | 1 | 2001 | 29 | 0.050 |
Why?
|
Databases, Protein | 1 | 2002 | 390 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2009 | 6214 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5873 | 0.040 |
Why?
|
Hepatitis, Chronic | 1 | 2000 | 53 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20146 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4853 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 9077 | 0.040 |
Why?
|
DNA Restriction Enzymes | 1 | 1999 | 548 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2006 | 1540 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4401 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2003 | 665 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2002 | 2177 | 0.040 |
Why?
|
Uric Acid | 1 | 2024 | 809 | 0.040 |
Why?
|
Sodium | 1 | 2003 | 1594 | 0.040 |
Why?
|
Death | 1 | 2023 | 685 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2144 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2000 | 1622 | 0.040 |
Why?
|
Attitude to Computers | 1 | 1999 | 196 | 0.040 |
Why?
|
F Factor | 1 | 2017 | 12 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2006 | 2353 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4215 | 0.040 |
Why?
|
Expert Testimony | 1 | 2019 | 266 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2013 | 22248 | 0.030 |
Why?
|
Biotechnology | 1 | 1999 | 283 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1226 | 0.030 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2016 | 13 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3266 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 2000 | 458 | 0.030 |
Why?
|
Base Sequence | 2 | 1999 | 12415 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1972 | 0.030 |
Why?
|
Turtles | 1 | 1996 | 40 | 0.030 |
Why?
|
Feedback | 1 | 2000 | 797 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 937 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5306 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11514 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4860 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1791 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 1999 | 13411 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2019 | 642 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1996 | 774 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15831 | 0.030 |
Why?
|
Dyspnea | 1 | 2003 | 1352 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10745 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10580 | 0.030 |
Why?
|
Demography | 1 | 2000 | 1641 | 0.030 |
Why?
|
Primary Prevention | 1 | 2023 | 1188 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2000 | 1838 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 13090 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2011 | 7869 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 499 | 0.030 |
Why?
|
Drug Design | 1 | 1999 | 1043 | 0.030 |
Why?
|
Electric Countershock | 1 | 2017 | 534 | 0.030 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2014 | 146 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1996 | 647 | 0.030 |
Why?
|
Audiovisual Aids | 1 | 2014 | 97 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2228 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 59939 | 0.030 |
Why?
|
Multigene Family | 1 | 1996 | 1081 | 0.030 |
Why?
|
Prospective Studies | 3 | 2017 | 54872 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2017 | 772 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2078 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3853 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3115 | 0.030 |
Why?
|
Lipids | 1 | 2003 | 3322 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2001 | 1324 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1065 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22351 | 0.020 |
Why?
|
Educational Measurement | 1 | 1999 | 1259 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13644 | 0.020 |
Why?
|
Adolescent | 1 | 2020 | 88902 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2011 | 262 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3431 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12795 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2131 | 0.020 |
Why?
|
Information Systems | 1 | 2013 | 400 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4168 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4340 | 0.020 |
Why?
|
Diet, Sodium-Restricted | 1 | 2011 | 291 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5783 | 0.020 |
Why?
|
Alcoholism | 1 | 2000 | 1980 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7571 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3951 | 0.020 |
Why?
|
Angiotensin II | 1 | 2011 | 843 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3905 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 935 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2016 | 1838 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12985 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2011 | 337 | 0.020 |
Why?
|
Animals | 4 | 2011 | 168939 | 0.020 |
Why?
|
Cardiology | 1 | 2019 | 1701 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7430 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 548 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2007 | 0.020 |
Why?
|
Seizures | 1 | 2000 | 2996 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6066 | 0.020 |
Why?
|
Rheumatology | 1 | 2013 | 619 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12826 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9602 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16722 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2014 | 1790 | 0.010 |
Why?
|
Program Development | 1 | 2011 | 1297 | 0.010 |
Why?
|
Physician's Role | 1 | 2011 | 925 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15912 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2009 | 811 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2043 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2006 | 540 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81898 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17609 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2017 | 2787 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7841 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2505 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3723 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2011 | 1445 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3582 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2006 | 949 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18986 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13476 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8728 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23618 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 26309 | 0.000 |
Why?
|
Recurrence | 1 | 2001 | 8507 | 0.000 |
Why?
|
Neoplasms | 1 | 2014 | 22350 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 36570 | 0.000 |
Why?
|